Ameliorative effect of PN-277 on laser-induced retinal damage

Graefe's Archive for Clinical and Experimental Ophthalmology

Volumn 247, Issue 3, 2009, Pages 343-348

  Shulman, Shiri ^a   Belokopytov, Mark ^b,c   Dubinsky, Galina ^b   Belkin, Michael ^b   Rosner, Mordechai ^b  

^a Sapir Medical Centre   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

^c SHEBA MEDICAL CENTER   (Israel)

Author keywords

Immunomodulation; Laser injury; Neuroprotection; Retina; Retinal injury

Indexed keywords

IMMUNOLOGIC AGENT; PN 277; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARGON LASER; ARTICLE; CELL DENSITY; CONTROLLED STUDY; DRUG EFFICACY; DRUG RESPONSE; HISTOCHEMISTRY; IMMUNIZATION; LASER INDUCED RETINA INJURY; MORPHOMETRICS; NEUROPROTECTION; NONHUMAN; PHOTORECEPTOR CELL; PRIORITY JOURNAL; RAT; RETINA INJURY;

ANIMALS; DISEASE MODELS, ANIMAL; EYE INJURIES; IMMUNOSUPPRESSIVE AGENTS; INJECTIONS, INTRAPERITONEAL; LASER COAGULATION; LASERS, GAS; NEUROPROTECTIVE AGENTS; PEPTIDES; RATS; RETINA; RETINAL DISEASES;

EID: 59749093026     PISSN: 0721832X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00417-008-0975-4     Document Type: Article

References (24)

1. Yoles E, Schwartz M (1998) Degeneration of spared axons following partial white matter lesion: Implications for optic nerve neuropathies. Exp Neurol 153:1-7. doi: 10.1006/exnr.1998.6811
2. Kristian T, Siesjo BK (1996) Calcium-related damage in ischemia. Life Sci 59:357-367. doi: 10.1016/0024-3205(96)00314-1
3. Neufeld AH, Hernandez MR, Gonzalez M (1997) Nitric oxide synthase in the human glaucomatous optic nerve head. Arch Ophthalmol 115:497-503
4. Osborne NN, Chidlow G, Wood JP, Schmidt KG, Casson R, Melena J (2001) Expectations in the treatment of retinal diseases: Neuroprotection. Curr Eye Res 22:321-332. doi: 10.1076/ceyr.22.5.321.5496
5. Solberg Y, Rosner M, Turetz J, Belkin M (1997) MK-801 has neuroprotective and antiproliferative effects in retinal laser injury. Invest Ophthalmol Vis Sci 38:1380-1389
6. Osborne NN (1999) Memantine reduces alterations to the mammalian retina, in situ, induced by ischemia. Vis Neurosci 16:45-52. doi: 10.1017/ S0952523899161017
7. Moalem G, Leibowitz-Amit R, Yoles E, Mor F, Cohen IR, Schwartz M (1999) Autoimmune T cells protect neurons from secondary degeneration after central nervous system axotomy. Nat Med 5:49-55. doi: 10.1038/4734
8. Kerschensteiner M, Gallmeier E, Behrens L, Leal VV, Misgeld T, Klinkert WE, Kolbeck R, Hoppe E, Oropeza-Wekerle RL, Bartke I, Stadelmann C, Lassmann H, Wekerle H, Hohlfeld R (1999) Activated human T cells, B cells, and monocytes produce brain-derived neurotrophic factor in vitro and in inflammatory brain lesions: A neuroprotective role of inflammation? J Exp Med 1(189):865-870
9. Schori H, Kipnis J, Yoles E, WoldeMussie E, Ruiz G, Wheeler LA et al (2001) Vaccination for protection of retinal ganglion cells against death from glutamate cytotoxicity and ocular hypertension: Implications for glaucoma. Proc Natl Acad Sci USA 98:3398-3403. doi: 10.1073/ pnas.041609498
10. Belokopytov M, Dubinsky G, Belkin M, Epstein Y, Rosner M (2005) Copolymer-1 vaccination regimens for neuroprotection in laser-induced retinal injuries. In: Manns F, Soderberg P, Ho A, Stuck BE, Belkin M (eds) Ophthalmic technologies XV. SPIE, Bellingham, Washington, USA, pp 329-336
11. Ben-Shlomo G, Belokopytov M, Rosner M, Dubinsky G, Belkin M, Epstein Y et al (2006) Functional deficits resulting from laser-induced damage in the rat retina. Lasers Surg Med 38:689-694. doi: 10.1002/lsm.20351
12. Prendiville PL, McDonnell PJ (1992) Complications of laser surgery. Int Ophthalmol Clin 32:179-204. doi: 10.1097/00004397-199223000-00012
13. Barkana Y, Belkin M (2000) Laser eye injuries. Surv Ophthalmol 44:459-478. doi: 10.1016/S0039-6257(00)00112-0
14. Liu HF, Gao GH, Wu DC, Xu GD, Shi LS, Xu JM et al (1989) Ocular injuries from accidental laser exposure. Health Phys 56:711-716
15. Schwartz M, Kipnis J (2005) Protective autoimmunity and neuroprotection in inflammatory and noninflammatory neurodegenerative diseases. J Neurol Sci 233:163-166. doi: 10.1016/j.jns.2005.03.014
16. Hauben E, Nevo U, Yoles E, Moalem G, Agranov E, Mor F et al (2000) Autoimmune T cells as potential neuroprotective therapy for spinal cord injury. Lancet 355:286-287. doi: 10.1016/S0140-6736(99)05140-5
17. Schwartz M, Cohen IR (2000) Autoimmunity can benefit self-maintenance. Immunol Today 21:265-268. doi: 10.1016/S0167-5699(00)01633-9
18. Hirschberg DL, Moalem G, He J, Mor F, Cohen IR, Schwartz M (1998) Accumulation of passively transferred primed T cells independently of their antigen specificity following central nervous system trauma. J Neuroimmunol 89:88-96. doi: 10.1016/S0165-5728(98)00118-0
19. Fisher J, Levkovitch-Verbin H, Schori H, Yoles E, Butovsky O, Kaye JF et al (2001) Vaccination for neuroprotection in the mouse optic nerve: implications for optic neuropathies. J Neurosci 21:136-142
20. Bakalash S, Kessler A, Mizrahi T, Nussenblatt R, Schwartz M (2003) Antigenic specificity of immunoprotective therapeutic vaccination for glaucoma. Invest Ophthalmol Vis Sci 44:3374-3381. doi: 10.1167/ iovs.03-0080
21. Kipnis J, Schwartz M (2002) Dual action of glatiramer acetate (Cop-1) in the treatment of CNS autoimmune and neurodegenerative disorders. Trends Mol Med 8:319-323. doi: 10.1016/S1471-4914(02)02373-0
22. Arnon R, Sela M, Teitelbaum D (1996) New insights into the mechanism of action of copolymer 1 in experimental allergic encephalomyelitis and multiple sclerosis. J Neurol 243:S8-S13. doi: 10.1007/BF00873696
23. Moalem G, Gdalyahu A, Shani Y, Otten U, Lazarovici P, Cohen IR et al (2000) Production of neurotrophins by activated T cells: Implications for neuroprotective autoimmunity. J Autoimmun 15:331-345. doi: 10.1006/ jaut.2000.0441
24. Hauben E, Gothilf A, Cohen A, Butovsky O, Nevo U, Smirnov I et al (2003) Vaccination with dendritic cells pulsed with peptides of myelin basic protein promotes functional recovery from spinal cord injury. J Neurosci 23:8808-8819